SymBio Pharmaceuticals Limited
SYMQY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $3,964 | $6,517 | $6,283 | $3,860 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $423 | $0 | $2,085 | $2,148 |
| Inventory | $239 | $232 | $469 | $386 |
| Other Curr. Assets | $299 | $1,333 | $476 | $355 |
| Total Curr. Assets | $4,924 | $8,083 | $9,313 | $6,748 |
| Property Plant & Equip (Net) | $44 | $88 | $154 | $170 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $222 | $259 |
| Long-Term Investments | $0 | $87 | $85 | -$87 |
| Tax Assets | $0 | $0 | $745 | $1,276 |
| Other NC Assets | $0 | -$87 | -$85 | $87 |
| Total NC Assets | $44 | $88 | $1,121 | $1,705 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $4,968 | $8,170 | $10,433 | $8,453 |
| Liabilities | – | – | – | – |
| Payables | $0 | $0 | $47 | $70 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $102 | $18 | $401 | $900 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $664 | $938 | $1,476 | $549 |
| Total Curr. Liab. | $766 | $957 | $1,924 | $1,518 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $6,995 | $6,724 |
| Other NC Liab. | $5 | $4 | $3 | $189 |
| Total NC Liab. | $5 | $4 | $3 | $189 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $771 | $960 | $1,927 | $1,707 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $18,337 | $17,952 | $17,548 | $17,158 |
| Retained Earnings | -$32,686 | -$28,852 | -$26,889 | -$27,978 |
| AOCI | $0 | $0 | $412 | $519 |
| Other Equity | $18,547 | $18,110 | $17,847 | $17,566 |
| Total Equity | $4,198 | $7,210 | $8,506 | $6,746 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $4,968 | $8,170 | $10,433 | $8,453 |
| Net Debt | -$3,964 | -$6,517 | -$6,283 | -$3,860 |